Canada markets open in 8 hours 4 minutes

Cara Therapeutics, Inc. (CARA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.7586+0.0067 (+0.89%)
At close: 04:00PM EDT
0.7700 +0.01 (+1.50%)
After hours: 07:33PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 40.37M
Enterprise Value -54.30M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.91
Price/Book (mrq)0.71
Enterprise Value/Revenue -2.59
Enterprise Value/EBITDA 0.46

Trading Information

Stock Price History

Beta (5Y Monthly) 0.70
52-Week Change 3-82.55%
S&P500 52-Week Change 323.57%
52 Week High 34.6700
52 Week Low 30.5000
50-Day Moving Average 30.8333
200-Day Moving Average 31.3525

Share Statistics

Avg Vol (3 month) 3623.86k
Avg Vol (10 day) 3283.65k
Shares Outstanding 554.67M
Implied Shares Outstanding 654.67M
Float 839.36M
% Held by Insiders 114.43%
% Held by Institutions 148.28%
Shares Short (Apr 15, 2024) 42.61M
Short Ratio (Apr 15, 2024) 46.23
Short % of Float (Apr 15, 2024) 45.55%
Short % of Shares Outstanding (Apr 15, 2024) 44.77%
Shares Short (prior month Mar 15, 2024) 42.48M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,085.45%

Management Effectiveness

Return on Assets (ttm)-49.29%
Return on Equity (ttm)-109.80%

Income Statement

Revenue (ttm)20.97M
Revenue Per Share (ttm)0.39
Quarterly Revenue Growth (yoy)-7.90%
Gross Profit (ttm)N/A
EBITDA -121.24M
Net Income Avi to Common (ttm)-118.51M
Diluted EPS (ttm)-2.1900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)100.76M
Total Cash Per Share (mrq)1.84
Total Debt (mrq)43.17M
Total Debt/Equity (mrq)75.62%
Current Ratio (mrq)4.54
Book Value Per Share (mrq)1.05

Cash Flow Statement

Operating Cash Flow (ttm)-92.08M
Levered Free Cash Flow (ttm)-52.53M